Polysaccharide vaccines as probes of antibody repertoires in man

Immunological Reviews

Volumn 171, Issue , 1999, Pages 89-104

  Lucas, Alexander H ^a,b   Reason, Donald C ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; POLYSACCHARIDE VACCINE;

BACTERIAL IMMUNITY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; EVOLUTION, MOLECULAR; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MODELS, IMMUNOLOGICAL; POLYSACCHARIDES, BACTERIAL;

EID: 0032748260     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01343.x     Document Type: Review

References (76)

1. 1. Jerne NK. Waiting for the end. Cold Spring Harb Symp Quant Biol 1967;32:591-603.
2. 2. Robbins JB, Schneerson R, Pittman M. Haemophilus influenzae type b infections. In: Germanier R, ed. Bacterial vaccines. Orlando; Academic Press; 1984. p. 289-316.
3. 3. Fothergill L, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933;24:273-284.
4. 4. Robbins JB, Schneerson R, Anderson P, Smith DH. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: impact on public health and implication for other polysaccharide-based vaccines. JAMA 1996;276:1181-1185.
5. 5. Schneerson R, Barrera O, Sutton A, Robbins JB. Preparation, characterization and immunogenicity of H. influenzae b polysaccharide-protein conjugates. J Exp Med 1980;152:361-367.
6. 6. Ellis RW, Granoff DM, eds. Development and clinical uses of Haemophilus b conjugate vaccines. New York: Marcel Dekker, Inc; 1994.
7. 7. Murphy TV, et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 1993;269:246-248.
8. 8. Rijkers GT, Sanders EAM, Breukels MA, Zegers BJM. Infant B cell responses to polysaccharide determinants. Vaccine 1998;16:1396-1400.
9. 9. Markham RB, Nicholson-Weller A, Schiffman G, Kasper DL. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol 1982;128:2731-2733.
10. 10. Hostetter MK. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 1986;153:682-693.
11. 11. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348-350.
12. 12. Hougs L, Juul L, Ditzel HJ, Heilman H, Svejgaard, Barington T. The first dose of a Haemophilus influenzae type b conjugate vaccine reactivates memory B cells: evidence for extensive clonal selection, intraclonal affinity maturation, and multiple isotype switches to IgA2. J Immunol 1999;162:223-237.
13. 13. Granoff DM, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1992;168:663-671.
14. 14. Smith DH, Peter G, Ingram DL, Harding AL, Anderson P. Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae, type b. Pediatrics 1973;52:637-644.
15. 15. Eskola J, et al. A randomized, prospective field trial of a conjugate vaccine in protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990;323:1381-1387.
16. 16. Ward J, Brenneman G, Letson GW, Heyward WL. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska native infants. N Engl J Med 1990;323:1393-1401.
17. 17. Lucas AH. Genetic basis and somatic evolution of a human polysaccharide-specific antibody repertoire. In: Zouali M, ed. Human B cell superantigens. New York: Springer; 1996.
18. 18. Padlan EA, Kabat EA. Model building study of the combining sites of two antibodies to α(1-6)dextran. Proc Natl Acad Sci USA 1988;85:6885-6889.
19. 19. Lucas AH, Langley RJ, Granoff DM, Nahm MH, Kitamura MY, Scott MG. An idiotypic marker associated with a germ line encoded κ light chain variable region that predominates the vaccine induced human antibody response to Haemophilus influenzae b polysaccharide. J Clin Invest 1991;88:1811-1818.
20. 20. Reason DC, Lucas AH. Functional expression of the IGKV A18b gene and its idiotypioc cross-reactivity with the A2 variable region. Immunogenetics 1997;45:343-344.
21. 21. Granoff DM, Shackelford PG, Holmes SJ: The Collaborative Vaccine Study Group, Lucas AH. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates: description of a new λ light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. J Clin Invest 1993;91:788-796.
22. 22. Lucas AH. Probing human polysaccharide antibody repertoires using anti-idiotypes. In: Schoenfeld Y, Kennedy RC, Ferrone S, eds. Idiotypes in medicine: Autoimmunity, infection and cancer. Amsterdam: Elsevier; 1997. p. 395-405.
23. + B cells. J Clin Invest 1997;99:1614-1627.
24. 24. Insel RA, Anderson PW. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the H. influenzae b capsular polysaccharide in human infants. J Exp Med 1986;163:262-269.
25. 25. Insel RA, Kittelberger A, Anderson P. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J Immunol 1985;135:2810-2816.
26. 26. Reisen WF, Skvaril F, Braun DG. Natural infection of man with group A streptococci. Levels, restriction in class, subclass and type, and clonal appearance of polysaccharide-group specific antibodies. Scand J Immunol 1976;5:383-390.
27. 27. Konradsen H, Hahn-Zoric M, Hanson LÄ. Differences within mono and dizygotic twin-pairs in spectrotypes and clones of IgG2 antibodies to pneumococcal polysaccharide type-1 and C-polysaccharide after vaccination. Scand J Immunol 1994;40:423-428.
28. 28. Park MK, Sun Y, Olander JV, Hoffmann JW, Nahm MH. The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B. J Infect Dis 1996;174:75-82.
29. 29. Lucas AH, Granoff DM, Mandrell, Connolly CC, Shan AS, Powers DC. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14 and 23F. Infect Immun 1997;65:5103-5109.
30. 30. Lucas AH, Granoff DM. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type b polysaccharide-protein conjugates. J Immunol 1995;154:4195-4202.
31. 31. Chen C, Bruderer U, Rittenberg MB. The developmental patterns of B cell precursors distinguishing between environmental and nonenvironmental forms of phosphocholine. Cell Immunol 1992;143:378-388.
32. 32. Scott MG, et al. Clonal characterization of the human antibody repertoire to Haemophilus influenzae b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families. J Immunol 1989;143:293-298.
33. 33. Augustin A, Cosenza H. Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol 1976;6:497-501.
34. 10) terpolymer and bacterial levan in κ-deficient mice. Eur J Immunol 1995;25:1039-1043.
35. 35. Usinger WR, Lucas AH. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect Immun 1999;67:2366-2370.
36. 36. Feeney AJ, Atkinson MJ, Cowan MJ, Escuro G, Lugo G. A defective VκA2 allele in navajos which may play a role in increased susceptibility to to Haemophilus inlfuenzae type b disease. J Clin Invest 1996;97:2277-2282.
37. 37. Nadel B, Tang A, Lugo G, Love V, Escuro G, Feeney AJ. Decreased frequency of rearrangment due to the synergistic effect of nucleotide changes in the heptamer and nonamer of the recombination signal sequence of the Vκ gene A2b, which is associated with increased susceptibility of Navajos to Haemophilus inlfuenzae type b disease. J Immunol 1998;161:6068-6073.
38. 38. Musher DM, et al. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Invest Med 1997;45:57-68.
39. 39. Schroeder HW, Wang JY. Preferential utilization of conserved immunoglobulin heavy chain variable region gene segments during human fetal life. Proc Nat Acad Sci USA 1990;87:6146-6150.
40. 40. Schroeder HW, Hillson JL, Perlmutter RM. Early restriction of the human antibody repertoire. Science 1987;238:791-793.
41. 41. Einhorn MS, Weinberg GA, Anderson EL, Granoff PD, Granoff DM. Immunogenicity in infants of Haemophilus influenzae type b polysaccharide in a conjugate vaccine with Neisseria meningitidis outer membrane protein. Lancet 1986;2:299-302.
42. 42. Feeney AJ, Lugo G, Escuro G. Human cord blood κ repertoire. J Immunol 1997;158:3761-3768.
43. 43. Miller RA The aging immune system: primer and prospectus. Science 1996;273:70-74.
44. 44. Nicoletti, C, Borghesi-Nicoletti C, Yang X, Schultze DH, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J Immunol 1991;147:2750-2755.
45. 45. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993;150:543-549.
46. 46. Lucas AH, Reason DC. Aging and the immune response to the Haemophilus influenzae type b capsular polysaccharide: retention of the dominant idiotype and antibody function in the elderly. Infect Immun 1998;66:1752-1754.
47. 47. Schlesinger Y, Granoff DM, The Collaborative Vaccine Study Group. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 1992;267:1489-1494.
48. 48. Amir J, Liang X, Granoff DM. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr Res 1990;27:358-364.
49. 49. Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Nat Acad Sci USA 1991;88:7978-7982.
50. 50. Reason DC, Wagner TC, Lucas AH. Human Fab fragments specific for the Haemophilus influenzae b polysaccharide isolated from a bacteriophage library use variable region gene combinations and express idiotype that mirrors in vivo expression. Infect Immun 1997;65:261-266.
51. 51. Lucas AH, Moulton KD, Reason DC. Role of κTI-A2 light chain CDR-3 junctional resdiues in human antibody bindng to the Haemophilus influenzae type b polysaccharide. J Immunol 1998;161:3776-3780.
52. 52. Ermert K, Mitlohner H, Schempp W, Zachau HG. The immunoglobulin κ locus of primates. Genomics 1995;25:623-629.
53. 53. Atkinson MJ, Cowan MJ, Feeney AJ. New alleles of IGKV genes A2 and A18 suggest significant human IGKV locus polymorphism. Immunogenetics 1996;44:115-120.
54. 54. Juul L, et al. Population studies of the human VκA18 gene polymorphism in Caucasians, blacks and Eskimos: new functional alleles and evidence for evolutionary selection of a more restricted antibody repertoire. Tissue Antigens 1997;49:595-604.
55. 55. Reason DC, Wagner TC, Tang VR, Moulton KD, Lucas AH. Polysaccharide binding potential of the human A2 or A18 κ light chain homologues. Infect Immun 1999;67:994-997.
56. 56. Cohn M, Langman RE. The protecton: the unit of humoral immunity selected by evolution. Immunol Rev 1990;115:7-142.
57. 57. Langman RE, Cohn M. What is the selective pressure that maintains the gene loci encoding the antigen receptors of T and B cells? A hypothesis. Immunol Cell Biol 1992;70:397-404.
58. 58. Reason DC, Lucas AH. Content and dynamics of the human antibody variable region repertoire to the Haemophilus influenzae type b polysaccharide. Springer Semin Immunopathol 1993;15:119-137.
59. 59. Santosham M, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324:1767-1772.
60. 60. Schaible G, Rappold GA, Pargent W, Zachau HG. The immunoglobulin κ locus: polymorphism and haplotypes of Caucasoid and non-Caucasoid individuals. Hum Genet 1993;91:261-267.
61. 61. Holmes SJ, Lucas AH, Osterholm MT, Froeschle JE, Granoff DM, The Collaborative Study Group. Immunoglobulin deficiency and idiotype expression in childen developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. JAMA 1991;266:1960-1965.
62. 62. Cortese MM, Wolff M, Almeido-Hill J, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache popluation. Arch Int Med 1992;152:2277-2282.
63. 63. Coleclough C. A critique of the Cohn-Langman protecton theory. Immunol Rev 1990;115:173-181.
64. 64. Kirkham PM, Mortari F, Newton JA, Schroeder HW. Immunoglobulin VH clan and family predicts variable domain structure and may influence antigen binding. EMBO J 1992;11:603-609.
65. 65. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987;196:901-917.
66. 66. Scott MG, et al. Clonal characterization of the human antibody repertoire to Haemophilus influenzae b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families. J Immunol. 1989;143:293-298.
67. 67. Scott MG, et al. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III: a single VκH gene and one of several J genes are joined by an invariant arginine to form most common L chain V region. J Immunol 1989;143:4110-4116.
68. 68. Scott MG, et al. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous. J Immunol 1991;147:4007-4013.
69. 69. Adderson EE, et al. Restricted Ig heavy chain usage in the human antibody response to Haemophilus influenzae type b polysaccharide. J Immunol 1991;147:1667-1674.
70. 70. Adderson EE, et al. Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b polysaccharide are dominated by a limited number of Vκ and Vλ segments and VJ recombinations. J Clin Invest 1992;89:729-738.
71. 71. Adderson EE, et al. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b polysaccharide: nucleotide sequences of monospecific anti Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J Clin Invest 1993;91:2734-2743.
72. 72. Adderson EE, et al. The human VH3b gene subfamily is highly polymorphic. J Immunol 1993;151:800-809.
73. 73. Lucas AH, Larrick JW, Reason DC. Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b polysaccharide. Infect Immun 1994;62:3873-3880.
74. 74. Pinchuk GV, Nottenburg C, Milner ECB. Predominant V-region gene configurations in the human antibody response to Haemophilus influenzae capsule polysaccharide. Scand J Immunol 1995;41:324-330.
75. 75. Barington T, et al. The progeny of a single virgin B cell predominates the human recall B cell response to the capsular polysaccharide of Haemophilus influenzae type b. J Immunol 1996;157:4016-4027.
76. 76. Lucas AH, Azmi FH, Mink CM, Granoff DM. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J Immunol 1993;150:2056-2061.